InvestorsHub Logo
Followers 5
Posts 289
Boards Moderated 0
Alias Born 02/24/2016

Re: jimmy667 post# 73607

Tuesday, 08/16/2016 2:24:54 PM

Tuesday, August 16, 2016 2:24:54 PM

Post# of 473001
Similar partnership news could come tomorrow for AVXL, STEM up 461% on the news. Interesting that the big move in this penny stock occurred after what the CEO said after modest phase 2 clinical trial results:

“This transaction concludes an extensive search for strategic alternatives conducted by StemCells since we failed to see robust clinical results in our Phase II clinical study of human neural stem cells in chronic spinal cord injury,” said Ian Massey, the CEO of StemCells, Inc.

Anything is possible, IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News